The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized intermittent or continuous panitumumab plus FOLFIRI (FOLFIRI/PANI) for first-line treatment of patients (pts) with RAS/BRAF wild-type (wt) metastatic colorectal cancer (mCRC): The IMPROVE study.
 
Antonio Avallone
Honoraria - Eisai; MSD
Consulting or Advisory Role - Amgen; AstraZeneca
 
Francesco Giuliani
No Relationships to Disclose
 
Guglielmo Nasti
No Relationships to Disclose
 
Vincenzo Montesarchio
No Relationships to Disclose
 
Giuseppe Santabarbara
Consulting or Advisory Role - Amgen/Dompé; Merck Serono; SERVIER
 
Silvana Leo
No Relationships to Disclose
 
Alfonso De Stefano
Employment - Bristol-Myers Squibb (I)
Honoraria - Amgen; Roche
Consulting or Advisory Role - Amgen
Travel, Accommodations, Expenses - Amgen; SERVIER
 
Gerardo Rosati
No Relationships to Disclose
 
Ivan Lolli
No Relationships to Disclose
 
Emiliano Tamburini
No Relationships to Disclose
 
Alfredo Colombo
No Relationships to Disclose
 
Daniele Santini
No Relationships to Disclose
 
Lucrezia Silvestro
No Relationships to Disclose
 
Gaetano Facchini
No Relationships to Disclose
 
Francesco Mannavola
No Relationships to Disclose
 
Antonio Febbraro
No Relationships to Disclose
 
Giancarlo Troncone
No Relationships to Disclose
 
Alberto F. Sobrero
Stock and Other Ownership Interests - Bayer
Consulting or Advisory Role - Amgen; Bayer; Celgene; Menarini; Merck Serono; Roche; Sanofi; SERVIER
Speakers' Bureau - amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; celgene; Lilly; Merck Serono; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche; Takeda
 
Diana Giannarelli
No Relationships to Disclose
 
Alfredo Budillon
No Relationships to Disclose